Buscar resultados de ensayos clínicos

Patrocinado por

Epstein-Barr Virus Infections - 22 Studies Found

Estado Estudiar
Completed Nombre del estudio: A Study of the Safety and Efficacy of EBV Specific T-cell Lines
Condición:
  • Epstein-Barr Virus Infections
  • Post-Transplant Lymphoproliferati
    Fecha: 2015-10-15
    Intervenciones:
    • Biological: Group A Peptide-st
Completed Nombre del estudio: Activity of Valomaciclovir in Infectious Mononucleosis Due to Primary Epstein-Barr Virus Infection
Condición: Infectious Mononucleosis
Fecha: 2007-12-14
Intervenciones:
  • Drug: Valomaciclovir 4 grams o
Completed Nombre del estudio: Modified Vaccinia Ankara (MVA) Vaccine Study
Condición:
  • Nasopharyngeal Neoplasms
  • Epstein-Barr Virus Infections
    • Fecha: 2010-12-08
    Intervenciones: Drug: MVA Vaccine The starting dose will be 5 x 107 plaque forming units (pfu) given by intradermal vacc
Completed Nombre del estudio: EBV-Specific CTLs Following CD45 Antibody to Patients With Epstein-Barr Virus (EBV) + Nasopharyngeal Carcinoma (NPC)
Condición:
  • Nasopharyngeal Cancer
  • EBV Infections

Fecha: 2004-03-01
Intervenciones:
  • Biological: EBV specific CTL Infusion

Completed Nombre del estudio: The Prevelance Rate of Human Cytomegalovirus (HCMV), Epstein-Barr Virus (EBV) and Human Herpes Virus (HHV-6) in a Saliva of the Patient With Periodantitis
Condición:
  • Cytomegalovirus
  • Epstein-Barr Virus Infections
  • Transplantation Infection
  • Epstein-Barr Virus Infections
    • Fecha: 2013-10-10
    Intervenciones:
    • Drug: Valacyclovir Experimenta
Active, not recruiting Nombre del estudio: Bortezomib Plus Rituximab for EBV+ PTLD
Condición:
  • Post-transplant Lymphoproliferative Disease
  • Solid Organ Transplant
  • Drug: bortezomib Given intrave
No longer available Nombre del estudio: Allogeneic Virus-Specific Cytotoxic T-Lymphocytes(CTL), Persistent/Recurrent Viral Infection Post-HSCT (EAP CHALLAH)
Condición:
  • EBV Infection
  • CMV Infection
  • A
    Fecha: 2013-09-16
    Intervenciones: Biological: Trivirus-Specific CTLs Patients will receive up to 2 x 10^7 CHM-CTL/m2 as a single infusion
Completed Nombre del estudio: Surveillance Study of Viral Infections Following Lung Transplantation
Condición:
  • Lung Transplantation
  • Bronchiolitis Obliterans
  • Fecha: 2008-06-17
Completed Nombre del estudio: Administration of Rapidly Generated Multivirus-specific Cytotoxic T-Lymphocytes (VIRAGE)
Condición:
  • Adenovirus Infection
  • Epstein-Barr Virus Infections
  • Fecha: 2010-02-16
    Intervenciones: Biological: Multi-virus Specific T cells Subjects will rec
<<< Previous | Next >>>